Correlation Between Scholar Rock and Inhibrx
Can any of the company-specific risk be diversified away by investing in both Scholar Rock and Inhibrx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scholar Rock and Inhibrx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scholar Rock Holding and Inhibrx, you can compare the effects of market volatilities on Scholar Rock and Inhibrx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scholar Rock with a short position of Inhibrx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scholar Rock and Inhibrx.
Diversification Opportunities for Scholar Rock and Inhibrx
0.16 | Correlation Coefficient |
Average diversification
The 3 months correlation between Scholar and Inhibrx is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Scholar Rock Holding and Inhibrx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibrx and Scholar Rock is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scholar Rock Holding are associated (or correlated) with Inhibrx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibrx has no effect on the direction of Scholar Rock i.e., Scholar Rock and Inhibrx go up and down completely randomly.
Pair Corralation between Scholar Rock and Inhibrx
Given the investment horizon of 90 days Scholar Rock Holding is expected to under-perform the Inhibrx. But the stock apears to be less risky and, when comparing its historical volatility, Scholar Rock Holding is 1.13 times less risky than Inhibrx. The stock trades about -0.13 of its potential returns per unit of risk. The Inhibrx is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 1,514 in Inhibrx on December 29, 2024 and sell it today you would lose (82.00) from holding Inhibrx or give up 5.42% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Scholar Rock Holding vs. Inhibrx
Performance |
Timeline |
Scholar Rock Holding |
Inhibrx |
Scholar Rock and Inhibrx Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Scholar Rock and Inhibrx
The main advantage of trading using opposite Scholar Rock and Inhibrx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scholar Rock position performs unexpectedly, Inhibrx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibrx will offset losses from the drop in Inhibrx's long position.Scholar Rock vs. Revolution Medicines | Scholar Rock vs. Black Diamond Therapeutics | Scholar Rock vs. Passage Bio | Scholar Rock vs. Monte Rosa Therapeutics |
Inhibrx vs. Mirum Pharmaceuticals | Inhibrx vs. Rocket Pharmaceuticals | Inhibrx vs. Avidity Biosciences | Inhibrx vs. Uniqure NV |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Content Syndication Quickly integrate customizable finance content to your own investment portal |